NASDAQ | ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index.
The index is designed to provide exposure toU. S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 7.56% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 7.03% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 6.94% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 6.92% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 6.88% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.65% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.60% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 3.50% |
| CAH | Cardinal Health Inc | Healthcare | Medical Distribution | 3.47% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 3.31% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 3.27% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 3.17% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 2.94% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 2.64% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 2.60% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 2.45% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 2.15% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.97% |
| OGN | Organon & Co | Healthcare | Drug Manufacturers - General | 1.92% |
| CRL | Charles River Laboratories | Healthcare | Diagnostics & Research | 1.71% |